Award winning executive search to the private, and investor backed health, care, and life sciences sectors
Trusted executive search partner to the investment community delivering outstanding leaders for the healthcare and life sciences sectors
0
Mandates delivered to date
0
%
Delivery rate of all retained mandates
0
%
C-suite appointments are women
0
+
Sub-sectors in healthcare and life sciences supported
Healthcare news, data and analysis
Via Investors in Healthcare
UK: RLAM Property brings Shoreline Partners in house to scale UK healthcare infrastructure strategy
Royal London Asset Management (RLAM) Property is bringing UK healthcare real estate asset manager, Shoreline Partners, in-house as it looks to scale its investment in the UK’s healthcare infrastructure. It […]

UK: RLAM Property brings Shoreline Partners in house to scale UK healthcare infrastructure strategy
June 27, 2025
Care Homes
M&A
M&A Deals
News
Real Estate
KSA: SMC raises SAR1.875bn from IPO on Saudi Exchange
Specialized Medical Company (SMC), a leading healthcare provider in the Kingdom of Saudi Arabia (KSA), has completed its IPO raising gross proceeds of SAR1.875bn (US$500m), representing an implied market capitalization […]

KSA: SMC raises SAR1.875bn from IPO on Saudi Exchange
June 26, 2025
Healthcare
News
Public Equity
Bassam Chahine
EFG Hermes
India: HealthQuad appoints Rahul Agarwal as partner
HealthQuad, an India-based healthcare innovation fund, has appointed Rahul Agarwal as partner. He will lead the investment team and committee, a majority of whom have been instrumental in driving the […]

India: HealthQuad appoints Rahul Agarwal as partner
June 26, 2025
Healthcare
Life Sciences
News
People
Pharma
Belgium: Danone further expands into gut health with acquisition of TAC from Vives
Danone, a France-based global food and beverage company, is further investing in gut health and next-generation biotic research with the acquisition of Belgium-based The Akkermansia Company (TAC) from Vives Partners, […]

Belgium: Danone further expands into gut health with acquisition of TAC from Vives
June 26, 2025
Consumer Healthcare
Healthcare
M&A
News
Baker McKenzie
Germany: Brainlab spins off Snke prior to IPO
Brainlab, a Germany-based global medtech company has spun-off the Snke Group. Snke, led by Stefan Vilsmeier, acts as an orchestration layer that connects data points from various stakeholders, products and […]

Germany: Brainlab spins off Snke prior to IPO
June 26, 2025
Life Sciences
Medtech – Healthcare IT
News
Public Equity
Brainlab
Israel: ForSight Robotics secures US$125m Series B
Ophthalmic robotic surgery company, ForSight Robotics, has completed a US$125m Series B round, led by US-based PE and VC principals, Eclipse. The funding round included significant participation from an undisclosed […]

Israel: ForSight Robotics secures US$125m Series B
June 25, 2025
Life Sciences
Medtech – Hospital Equipment
News
Venture
Eclipse
Germany: Rantum increases loan in support of lab services company’s acquisition in South Africa
Rantum Capital, a mid-market financier for the German-speaking region (DACH), through its private debt fund III, hasincreased its senior secured term loan to an unidentified international lab services company. The […]

Germany: Rantum increases loan in support of lab services company’s acquisition in South Africa
June 25, 2025
Debt
News
Pharma
Services – CRO/CMO/CDMO
Chris Steinroeder
UK: Leerink opens first international office in London. Eric Stewart to lead firm’s European Healthcare effort
Leerink Partners, a specialized healthcare-focused investment bank, has opened its first international office in London, expanding its M&A advisory platform to better serve clients across Europe. “Expanding into London gives us the footprint on […]

UK: Leerink opens first international office in London. Eric Stewart to lead firm’s European Healthcare effort
June 24, 2025
Healthcare
Life Sciences
News
People
Pharma
South Africa: MLM Medical Labs acquires Cytespace Africa Laboratories
Germany-based MLM Medical Labs, an international central and specialty laboratory, has acquired Cytespace Africa Laboratories, a premier ISO 15189 and CAP-accredited central laboratory based in Pretoria, South Africa. The acquisition expands […]

South Africa: MLM Medical Labs acquires Cytespace Africa Laboratories
June 24, 2025
M&A
News
Pharma
Services – CRO/CMO/CDMO
Cytespace Africa Laboratories
UK: Franklin Real Asset Advisors acquires care home portfolio from LDC Care Homes
Franklin Real Asset Advisors, on behalf of the Franklin Templeton Social Infrastructure Strategy, has acquired a portfolio of 32 care homes comprising approximately 1,500 beds across the UK, from LDC […]

UK: Franklin Real Asset Advisors acquires care home portfolio from LDC Care Homes
June 23, 2025
Care Homes
M&A
M&A Deals
News
Real Estate
UK: CVC launches CVC Catalyst – a sector agnostic PE strategy
Global investment firm, CVC, has launched CVC Catalyst, a sector agnostic private equity strategy focused on high-quality and faster growing mid-market businesses (<€250m equity investments), predominantly in Europe. CVC Catalyst will […]

UK: CVC launches CVC Catalyst – a sector agnostic PE strategy
June 23, 2025
Healthcare
Life Sciences
Pharma
Venture
CVC
Norway: PharmaLogic completes acquisition of majority stake in Agilera Pharma
PharmaLogic, a US-based CDMO specialized in radiopharmaceuticals, has acquired a majority stake in Norway-based Agilera Pharma, a Norway-based CDMO, from the Institute for Energy Technology (IFE) in Norway. It represents a step […]

Norway: PharmaLogic completes acquisition of majority stake in Agilera Pharma
June 23, 2025
M&A
News
Pharma
Services – CRO/CMO/CDMO
Agilera Pharma
Norway: Navamedic expands into addiction treatment and announces partially underwritten rights issue
Oslo-listed Navamedic, a Nordic pharmaceutical company and supplier of products to hospitals and pharmacies, has entered into an agreement to acquire the business of dne pharma, a Norwegian company focused on […]

Norway: Navamedic expands into addiction treatment and announces partially underwritten rights issue
June 23, 2025
M&A
Manufacturing – Specialty Pharma
News
Pharma
Public Equity
UK: Town Thorns Care Home joins Capital Care Group
Shropshire-based Capital Care Group has acquired Town Thorns Care Home from Ben Automotive Industry Charity, a move that represents a major strategic step for the group as it adds to […]

UK: Town Thorns Care Home joins Capital Care Group
June 20, 2025
Articles
Ben Automotive Industry Charity
Botham Capital
Capital Care Group
Charlotte Rawsthorne
UK: Bupa agrees terms to acquire New Victoria Hospital
British multinational health insurance and healthcare company, Bupa, has agreed terms to acquire New Victoria Hospital, an independent private hospital in Kingston upon Thames, in what represents Bupa’s first UK […]

UK: Bupa agrees terms to acquire New Victoria Hospital
June 19, 2025
Healthcare
Hospitals and Clinics
M&A
News
Bupa
Insights from EHIA’s First Edition of the Investors in Healthcare Private Capital Conference: resilient and attractive investment opportunities
The European Healthcare Investor Association – in partnership with Rothschild & Co and BCG – held its First Edition of the Investors in Healthcare Private Capital Conference at Dartmouth House in London on 3 […]

Insights from EHIA’s First Edition of the Investors in Healthcare Private Capital Conference: resilient and attractive investment opportunities
June 18, 2025
Buy Out
Healthcare
Life Sciences
News
Pharma
Germany: eutecma receives investment from Great Point Partners
eutecma, a Germany-based developer of sustainable, modular, and reusable temperature controlled packaging solutions for pharmaceutical cold chain shipments has received a strategic investment from Great Point Partners, a US-based private investment […]

Germany: eutecma receives investment from Great Point Partners
June 18, 2025
News
Pharma
Services – CRO/CMO/CDMO
Venture
Anja Bertrand
UK: Draig Therapeutics launches with US$140m to advance portfolio of next-generation therapies for major neuropsychiatric disorders
Draig Therapeutics (Draig), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, has emerged from stealth with a total of US$140m (£107m) raised over the last nine months. […]

UK: Draig Therapeutics launches with US$140m to advance portfolio of next-generation therapies for major neuropsychiatric disorders
June 18, 2025
Manufacturing – Specialty Pharma
News
Pharma
Venture
Access Biotechnology
Switzerland: Jacobs Holding and Telemos Capital join forces
London-based mid-market private equity firm, Telemos Capital, and Jacobs Holding, a Switzerland-based investment firm, both affiliated with the Jacobs family, are joining forces to form Jacobs Capital.The combination will build […]

Switzerland: Jacobs Holding and Telemos Capital join forces
June 18, 2025
Healthcare
News
Venture
Jacobs Capital
Nicolas Jacobs
Denmark: Asker to acquire Kirstine Hardam
Asker Healthcare Group has signed an agreement to acquire 100 per cent of the shares in Kirstine Hardam, one of Denmark’s largest suppliers of nursing supplies to regions, municipalities and […]

Denmark: Asker to acquire Kirstine Hardam
June 17, 2025
Distribution
Healthcare
M&A
News
Asker Healthcare Group
Germany: BioNTech to acquire CureVac in all-stock transaction
Nasdaq-listed BioNTech intends to acquire Germany-headquartered Nasdaq-listed CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on mRNA, in an all-stock transaction. […]

Germany: BioNTech to acquire CureVac in all-stock transaction
June 17, 2025
M&A
Manufacturing – Specialty Pharma
News
Pharma
Public Equity
UK: Limerston-backed Astoriom appoints Brittany Jackson as CFO
Astoriom, a UK-based company operating in the sample stability and biospecimen storage industry, has appointed Brittany Jackson as CFO. She brings a depth of experience spanning biotech, manufacturing, education, hospitality, and professional […]

UK: Limerston-backed Astoriom appoints Brittany Jackson as CFO
June 17, 2025
People
Pharma
Services – CRO/CMO/CDMO
Astoriom
Brittany Jackson
Singapore: Temasek-backed 65 Equity Partners makes significant minority investment in Allied OMS
Temasek-backed 65 Equity Partners has made a significant minority investment in Allied OMS, a US-based doctor-led management services organization (MSO) supporting oral and maxillofacial surgery practices across the US. Everberg […]

Singapore: Temasek-backed 65 Equity Partners makes significant minority investment in Allied OMS
June 16, 2025
Dental
Healthcare
News
Venture
65 Equity Partners
Sweden: CVC completes sale of its remaining shares in Synsam for approximately SEK1.1bn
Theia Holdings, a company indirectly owned by CVC Capital Partners, has sold its remaining shareholding in Synsam, the Nordic region’s leading player in optical retail, eye fashion and eye health, […]

Sweden: CVC completes sale of its remaining shares in Synsam for approximately SEK1.1bn
June 16, 2025
Cosmetic & Aesthetics
Healthcare
News
Ophthalmology
Public Equity
Canada: Northwest Healthcare Properties REIT appoints Zachary Vaughan as CEO
Toronto-listed Northwest Healthcare Properties REIT, an owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia, has appointed Zachary Vaughan as CEO in Toronto. He […]

Canada: Northwest Healthcare Properties REIT appoints Zachary Vaughan as CEO
June 16, 2025
Healthcare
Hospitals and Clinics
News
People
Real Estate
Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.

A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors












What our clients say

“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair

“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery

“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer

“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer

“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director

“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer

“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer

“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director

“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO

“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
The latest insights from
Compass Carter Osborne
Speak to our experts
Whether you’re looking to secure talented leaders for your business, or find a new role, Compass Carter Osborne can be trusted to deliver.